dz

dz dz

sq 中文
电话 0731-85681666-8006

dz

1
current position：
Homepage
/
发展历程
Congratulations to Sanjin Group Hunan Sanjin Pharmaceutical Co., LTD. Lamotrigine tablets the second national review!
2021-12-14

Congratulations to Sanjin Group Hunan Sanjin Pharmaceutical Co., LTD. Lamotrigine tablets the second national review!

On November 26, 2021, irbesartan hydrochlorothiazide tablets of Beijing Sihuan Kebao Pharmaceutical Co., Ltd. were approved
2021-11-29

On November 26, 2021, irbesartan hydrochlorothiazide tablets of Beijing Sihuan Kebao Pharmaceutical Co., Ltd. were approved

On November 19, 2021, faveravir tablets of Zhejiang Haizheng Pharmaceutical Co., Ltd. were approved
2021-11-22

On November 19, 2021, faveravir tablets of Zhejiang Haizheng Pharmaceutical Co., Ltd. were approved

On November 12, 2021, Hunan Mingrui Pharmaceutical Co., LTD., Propofol Tenofovir fumarate tablets were approved
2021-11-17

On November 12, 2021, Hunan Mingrui Pharmaceutical Co., LTD., Propofol Tenofovir fumarate tablets were approved

On January 1, 2021, tongnuo information released the internal test version of intelligent clinical research management platform (ICP)
2021-11-05

On January 1, 2021, tongnuo information released the internal test version of intelligent clinical research management platform (ICP)

On October 10, 2020, China's first intelligent laboratory management platform (ILP) was released
2021-11-05

On October 10, 2020, China's first intelligent laboratory management platform (ILP) was released

In July 2020, yootrial auth joined hands with Guangdong Hong Kong Macao alliance and Pacific Medical Subject Information Management System (escreening) to realize mutual check of subject identity information among the three systems
2021-11-05

In July 2020, yootrial auth joined hands with Guangdong Hong Kong Macao alliance and Pacific Medical Subject Information Management System (escreening) to realize mutual check of subject identity information among the three systems

September 9th, 2021, the first national approval of Ritonavir Tablets by Guli Pharmaceutical (Zhejiang) Co., Ltd.
2021-09-16

September 9th, 2021, the first national approval of Ritonavir Tablets by Guli Pharmaceutical (Zhejiang) Co., Ltd.

Previous page
1
2
…
14
go to page
jump

Online

Online

TEL

0731-85681666-8006

WeChat

WeChat

TOP

搜索
Search
dz

Service Hotline：

0731-85681666-8006

Copyright © 2021 Changsha Duxact Biotech Co., Ltd.     湘ICP备 16006884号-1
www.300.cn      Changsha